Navigation Links
BioElectronics Announces Significant Progress in Canadian and International Distribution
Date:10/21/2008

is clearly an exciting time for BioElectronics Corporation, our international distributors and our shareholders."

About BioElectronics Corporation

BioElectronics Corporation is the maker of the ActiPatch(R) Therapy. ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for about a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective patient friendly method to reduce soft tissue pain and swelling. ActiPatch Therapy is approved by Health Canada for the relief of pain in musculoskeletal complaints. The US government's food and drug administration (FDA) has cleared the use of the product for reducing edema (swelling) following blepharoplasty and the European Union has approved the product as a class two pulsed electromagnetic medical device as have numerous other international record for agencies.

Safe Harbor Statement

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies In light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the company has no control.
Media Contact:

Joe Noel, Emerging Growth Research LLP

Voice: 925-922-2560


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
2. BioElectronics Corp Aggressively Expands Sales into Middle East
3. BioElectronics Announces Distribution Agreement for Sales In India
4. BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even
5. BioElectronics Announces Conference Call to Update Investors on Growth Initiatives
6. BioElectronics Corporation Receives Major Orders From Italian Distributor
7. BioElectronics Launches 1 Day Breast Augmentation Recovery Kit
8. BioElectronics Announces Canadian Retail Product Launch
9. BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy
10. BioElectronics Corporation Announces Singapore and Malaysia Sales
11. Instrumentation Laboratory Announces Passion & Results Awards Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Nektar Therapeutics (Nasdaq: NKTR ) ... to serve on its board of directors. ... over 35 years of experience in corporate management, ... Nektar extensive industry perspective at an important time ... President and CEO of Nektar and member of ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) ... announced public offering have exercised in full their ... common stock at the public offering price of ... option increases the size of the offering to ... Dendreon expects to receive net proceeds from ...
(Date:12/11/2009)... ASA (OSE: ALGETA), the,cancer therapeutics company, announces ... the Tulane Cancer Center, New Orleans, has ... study of Alpharadin in men with,castration-resistant (also ... metastasized to the skeleton. , ... Prostate CAncer) study is a,double-blind, randomized, controlled ...
(Date:12/10/2009)... DNDN ) announced today that it has priced ... common stock at a price to the public of ... underwriters a 30-day option to purchase up to an ... if any. The offering is expected to close ... ,, J. P. Morgan Securities Inc. and Deutsche Bank ...
Breaking Biology Technology:Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3
... platform for treatment of Spinal Muscular Atrophy SOUTH PLAINFIELD, ... Inc. (PTC) and the Spinal Muscular Atrophy (SMA) Foundation ... which the SMA Foundation will provide up to $8.5 ... second continuation of the collaboration to fund a series ...
... EUROPE AND STRENGTHENS ITS SENIOR MANAGEMENT TEAM , ... OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader ... trials, today announced that it has strengthened its European ... Wolfgang Summa. As Executive Vice President, Europe & Asia/Pacific ...
... have come up with an explanation as to where and ... could turn out to be the first step on the ... of increasing oil production from Danish oil fields. , A ... of Chemistry at University of Copenhagen has investigated drill cores ...
Other Biology Technology:PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration 2PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration 3OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific 2OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific 3New Danish research shows how oil gets stuck underground 2
(Date:12/11/2009)... traditionally been limited by the seasons, particularly ... be short. Thanks to researchers and fruit ... that offer growers the ability to produce ... for both producers and consumers. Fresh examples ... "primocane-fruiting", which bear fruit on current-season canes, ...
(Date:12/11/2009)... smoking is a health risk but why do teens ... an evaluation for Faculty of 1000 Biology, Neil Grunberg ... abuse. , Grunberg describes the study, published by Natividad ... and suggests it "may have implications to help understand ... Nicotine increases the level of dopamine in the brain, ...
(Date:12/11/2009)... of hake, lumpsucker and salmon is the best dietary source ... researchers at the University of Almera (UAL). The scientists analysed ... all of these contained high levels of these fatty acids, ... there had been no precise understanding of the nutritional potential ... researchers from the UAL has now shown that this is ...
Breaking Biology News(10 mins):New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2CordLife Makes Headway into China 54519 1CordLife Makes Headway into China 54519 2CordLife Makes Headway into China 54519 3CordLife Makes Headway into China 54519 4CordLife Makes Headway into China 54519 5Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 1Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 2Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 3Cellworks Group and ISP Personal Care Collaborate to Demonstrate Effectiveness of Proteomics Based Computer Modeling of Skin Biology 13562 1Cellworks Group and ISP Personal Care Collaborate to Demonstrate Effectiveness of Proteomics Based Computer Modeling of Skin Biology 13562 2Cellworks Group and ISP Personal Care Collaborate to Demonstrate Effectiveness of Proteomics Based Computer Modeling of Skin Biology 13562 3Cellworks Group and ISP Personal Care Collaborate to Demonstrate Effectiveness of Proteomics Based Computer Modeling of Skin Biology 13562 4
... of aging on gene expression, researchers have found that ... with age. The findings, which impact our understanding of ... in the May 23rd issue of Current Biology by ... for Evolutionary Anthropology and the University of Cambridge. ...
... Researchers have found that abnormal stimulation of a ... cells in adults causes invasive tumor-like growths in ... to regress--a finding the researchers said suggests a ... called malignant gliomas. , Arturo Alvarez-Buylla and Erica ...
... journals published by BioMed Central, the open access publisher, ... journals in the top 10 of their 2005 Journal ... Impact Factor exceeding 3.00, open access journals are confirmed ... BioMed Central's flagship title covering biology in the post-genomic ...
Other Biology News:Gene expression becomes heterogeneous with age in humans and rats 2Possible birthplace of malignant brain tumors identified 2Impressive new Impact Factors for BioMed Central's open-access journals 2
... polyclonal to PAX3 This protein is ... family of transcription factors. Members of the ... domain and a paired-type homeodomain. These proteins ... in paired box gene 3 are associated ...
Mouse monoclonal antibody to RNase L...
Mouse polyclonal antibody to MCFD2 - multiple coagulation factor deficiency 2...
Anti (porcine) Vitronectin...
Biology Products: